(Q53090999)

11 May 2018

title

TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase. (English)

1 reference

11 May 2018

inflammatory breast cancer

main subject

inflammation

0 references

1 reference

10

1 reference

11 May 2018

Wendy A Woodward

Wendy A Woodward

7

0 references

Gabriel N Hortobagyi

11

Gabriel N Hortobagyi

1 reference

11 May 2018

Mien-Chie Hung

12

Mien-Chie Hung

1 reference

11 May 2018

Weiya Xia

4

Weiya Xia

1 reference

11 May 2018

Hitomi Saso

2

Hitomi Saso

1 reference

11 May 2018

author name string

Xiaoping Wang

1

1 reference

11 May 2018

Takayuki Iwamoto

3

1 reference

11 May 2018

Yun Gong

5

1 reference

11 May 2018

Lajos Pusztai

6

1 reference

11 May 2018

James M Reuben

8

1 reference

11 May 2018

Steven L Warner

9

1 reference

11 May 2018

Naoto T Ueno

13

1 reference

11 May 2018

language of work or name

English

0 references

publication date

6 September 2013

1 reference

11 May 2018

published in

Cancer Research

1 reference

11 May 2018

volume

73

1 reference

11 May 2018

issue

21

1 reference

11 May 2018

page(s)

6516-6525

1 reference

11 May 2018

Molecular characterisation of cell line models for triple-negative breast cancers

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Hyperosmotic stress induces Axl activation and cleavage in cerebral endothelial cells

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Tumor metastasis: mechanistic insights and clinical challenges

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Discovery of epigenetically masked tumor suppressor genes in endometrial cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Update on the management of inflammatory breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Recent developments in receptor-selective retinoids

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

Inflammatory breast cancer: a review

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6135947

The humoral immune system has a key prognostic impact in node-negative breast cancer

2 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24014597

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Aberrant promoter hypermethylation of tazarotine-induced gene 1 (TIG1) in head and neck cancer]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24014597

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Trends for Inflammatory Breast Cancer: Is Survival Improving?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24014597

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/0008-5472.CAN-13-0967

1 reference

11 May 2018

PMC publication ID

6135947

0 references

1 reference

11 May 2018